Dr. Oladeru is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Education & Training
- Johns Hopkins Carey Business School MBA, Healthcare Management, Leading Organizations, 2018 - 2021
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2017 - 2020
- NYU Long Island School of MedicineInternship, Preliminary Year, 2016 - 2017
- Stony Brook University Health Sciences Center School of MedicineClass of 2016
- Yale Graduate School of Arts & SciencesM.A., 2011 - 2012
- Yale UniversityB.S, B.A., 2007 - 2011
Certifications & Licensure
- FL State Medical License 2021 - 2025
Publications & Presentations
PubMed
- Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans.Oluwadamilola Oladeru, Fareed Rajack, Ashwini Esnakula, Tammey J Naab, Yasmine Kanaan
Biomedicines. 2024-07-09 - Inpatient Palliative Care and Healthcare Utilization Among Older Patients With Alzheimer's Disease and Related Dementia (ADRD) and High Risk of Mortality in U.S. Hospi...Zhigang Xie, Guanming Chen, Oluwadamilola T Oladeru, Hanadi Y Hamadi, Lucinda Montgomery
The American Journal of Hospice & Palliative Care. 2024-05-06 - Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.Jasmin Gill, Keerti Yendamuri, Udit Chatterjee, Song Yao, Oluwadamilola T Oladeru
BMC Cancer. 2024-04-13
Journal Articles
- Association of Endocrine Therapy with Overall Survival in Women with Small, Hormone Receptor–Positive, ERBB2-Negative Breast CancerOluwadamilola T Oladeru, Anurag K Singh, JAMA Network Open
Authored Content
- Association of Endocrine Therapy with Overall Survival in Women with Small, Hormone Receptor–Positive, ERBB2-Negative Breast CancerAugust 2020
Press Mentions
- U.S. Prisoners Face Higher Odds of Dying from CancerSeptember 27th, 2022
- Study Suggests Incarceration Is Linked to Higher Cancer DeathsSeptember 18th, 2022
- Breast, Cervical Screening Suboptimal in Transgender IndividualsMarch 11th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: